Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 42 min ago
Peer-reviewedCC BY 4.0JAMA Network Open

Reproductive Privacy Risk Disclosure in US Clinical Trial Informed Consent Forms After the Dobbs Decision

  • Ava Glazier1
  • Willyanne DeCormier Plosky1
  • Barbara E. Bierer1,2
  1. 1Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard, Division of Global Health, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts
  2. 2Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
Open at sourceDOICite

Abstract

This study examines the practice of pregnancy information disclosure by trial participants in the post– Dobbs v Jackson Women’s Health Organization US health research setting.

Related

  1. Navigating result disclosure in the context of reproductive genetic carrier screening: an interview study of genetic healthcare professionals in Belgium
    Kaatje Goossens, Pascal Borry, Eftychia Dimitriadou +1
    Journal of Community GeneticsPeer-reviewedLicence not statedFull textObstetrics, gynaecology & paediatricsPMC
  2. Choosing Between Anti-TROP2 ADCs in Advanced Breast Cancer Without Head-to-Head Evidence: A Practical Evidence-Informed Decision Framework Endorsed by the Polish Society of Clinical Oncology.
    Piotr J Wysocki, Katarzyna Pogoda, Ewa Wysocka +2
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  3. Supporting high-quality enrollment decision-making in clinical research: development of a novel informed consent communication framework and curriculum.
    Stephanie A Kraft, Kathryn M Porter, Abigail Brickler +14
    BMC medical research methodologyPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCPMC
  4. HIV serostatus disclosure to sexual partners and associated factors among reproductive-age women living with HIV in Lesotho: evidence from the 2023-2024 Lesotho Demographic and Health Survey.
    Alemayehu Kasu Gebrehana, Angwach Abrham Asnake
    Virology journalPeer-reviewedCC BY-NC-NDFull textInfectious diseaseEurope PMCPMC
  5. From Information to Insight: A Decision Architecture for Informed Governance.
    Jack A Cook
    Clinical pharmacology and therapeuticsPeer-reviewedCC BY-NC-NDFull textPharmacology & toxicologyEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{glazier2026reproductive,
  title = {{Reproductive Privacy Risk Disclosure in US Clinical Trial Informed Consent Forms After the Dobbs Decision}},
  author = {Ava Glazier and Willyanne DeCormier Plosky and Barbara E. Bierer},
  journal = {JAMA Network Open},
  year = {2026},
  month = oct,
  doi = {10.1001/jamanetworkopen.2026.37862},
  url = {https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2854934},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Reproductive Privacy Risk Disclosure in US Clinical Trial Informed Consent Forms After the Dobbs Decision
AU  - Ava Glazier
AU  - Willyanne DeCormier Plosky
AU  - Barbara E. Bierer
PY  - 2026
DA  - 2026/10/07
JO  - JAMA Network Open
DO  - 10.1001/jamanetworkopen.2026.37862
UR  - https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2854934
AB  - This study examines the practice of pregnancy information disclosure by trial participants in the post– Dobbs v Jackson Women’s Health Organization US health research setting.
SN  - 2574-3805
ER  -